221 followers
RT @mikegoodma: CStone Pharma $BPMC deal: 366k new cases of liver cancer in China each yr. Assuming FGFR4 drives ~33%, that yields an oppty…
RT @mikegoodma: CStone Pharma $BPMC deal: 366k new cases of liver cancer in China each yr. Assuming FGFR4 drives ~33%, that yields an oppty…
RT @mikegoodma: CStone Pharma $BPMC deal: 366k new cases of liver cancer in China each yr. Assuming FGFR4 drives ~33%, that yields an oppty…
CStone Pharma $BPMC deal: 366k new cases of liver cancer in China each yr. Assuming FGFR4 drives ~33%, that yields an oppty just for BLU-554 of 111k pts. $BPMC https://t.co/mKQqzu9ap5
The incidence and mortality of major cancers in China, 2012. https://t.co/82MMvs1cfM #breastcancer